newsfilter
← Latest News
ACCESS Newswire·

Biophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 19, 2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of therapeutics that are